Current Treatment Options in Cardiovascular Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.1 | Q4 | 19.4% | 0.347 | Q3 | 48.4% |
| 2024 | 0.6 | Q4 | 10.9% | 0.343 | Q3 | 49.9% |
| 2023 | 0.8 | Q4 | 22.3% | 0.395 | Q3 | 57.4% |
| 2022 | — | — | 0.444 | Q3 | 62.6% | |
| 2021 | — | — | 0.723 | Q2 | 78.4% | |
| 2020 | — | — | 0.724 | Q2 | 77.0% | |
| 2019 | — | — | 0.676 | Q2 | 76.0% | |
| 2018 | — | — | 0.651 | Q2 | 73.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1092-8464
ISSN
1534-3189
country
UScoverage
1999-2026